Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases is a NA clinical asset sponsored by Kuopio University Hospital in Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies. SEO and diligence focus: Gamma tACS (40 Hz) over the superior parietal cortex, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Alzheimer Disease
Modality: medical device
Target: Gamma tACS (40 Hz) over the superior parietal cortex
Sponsor: Kuopio University Hospital
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 25, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Gamma tACS (40 Hz) over the superior parietal cortex
View original source fields
Condition raw: Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies
Condition normalized: Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies
Modality raw: medical device
Modality normalized: medical device
Target raw: Gamma tACS (40 Hz) over the superior parietal cortex
Target normalized: Gamma tACS (40 Hz) over the superior parietal cortex